查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049430

生物晶片市場報告：按產品類型、製造技術、分析方法、應用、最終用戶和地區分類（2026-2034 年）

Biochips Market Report by Product Type, Fabrication Technique, Analysis Method, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球生物晶片市場規模達252億美元。展望未來，IMARC Group預測，2026年至2034年間，該市場將以12.88%的複合年成長率成長，到2034年達到776億美元。北美地區憑藉其強大的醫療保健體系、大量的研發投入和先進的醫療技術，正引領市場成長。推動市場穩定成長的因素包括：次世代定序和晶片實驗室技術的創新提升了生物晶片的功能；政府和私營部門對基因和分子研究的大量投入；以及對個人化醫療日益成長的需求。

隨著個人化醫療的日益普及，生物晶片正成為根據個人基因譜量身訂做治療方案的關鍵工具。這些晶片有助於識別基因突變、早期發現疾病並預測藥物反應，從而推動了醫療和製藥領域對生物晶片的需求。此外，生物晶片在即時診斷（POC）領域的應用也日益廣泛，因為即時結果對於決策至關重要。無論患者身處何地——診所、現場或家中——生物晶片都能提供快速且準確的結果，這正在徹底改變醫療保健的提供方式。此外，基因組學、蛋白質組學和分子生物學的進步使生物晶片成為分析生物檢體不可或缺的工具。這使得檢測和診斷更加快速且準確，因此生物晶片在實驗室、醫院和臨床環境中都至關重要。

生物晶片市場趨勢：

對個人化醫療的需求日益成長

醫療機構正日益採用個人化治療策略，關注每位患者獨特的基因組成和生物標記特徵。生物晶片是進行基礎基因評估的理想工具，而這些評估對於制定個人化治療策略至關重要。生物晶片能夠快速識別特定的基因突變、變異和基因表現，使醫療機構能夠為患者量身定做治療方案，從而獲得最佳療效。隨著精準醫療的興起，對能夠進行全面、高通量篩檢和診斷評估的生物晶片的需求日益成長。這些先進的生物晶片能夠處理複雜的生物訊息，支持更精準的治療，使醫生能夠為患者提供更優質的醫療服務。因此，生物晶片正成為推動個人化醫療持續發展的重要工具。

3D列印和微流體生物晶片的進展

3D列印和微流體生物晶片技術的進步正顯著推動生物晶片市場的發展。精確模擬人體器官功能的能力正在革新生命科學和藥物測試領域的研究。 2024年5月，波士頓微製造公司（BMF）成立了BMF生物技術公司，專門從事3D列印「晶片器官」生物晶片的研發。與傳統模型相比，這些微流體系統具有更高的生物學精確度，能夠更快、更準確地獲得研究結果。這項進步使得人體器官的模擬更加精確，從而改善了藥物測試、化妝品安全性評估和治療效果預測。這些創新正在拓展生物學研究的邊界，並為生物晶片的應用開闢新的可能性，尤其是在個人化醫療和藥物研發領域。 3D列印生物晶片技術的持續進步不斷提升其有效性，推動了許多研發和醫療領域對創新生物晶片技術的需求。

政府對生物技術的支持與投資

政府對生物技術的支持和定向投資是生物晶片市場成長的關鍵驅動力。各國政府正透過資助開創性項目，加速推動尖端生物晶片技術的進步，使其能夠應用於包括醫療、科學研究和高科技在內的廣泛領域。一個顯著的例子是，美國-以色列創新署於2024年撥款3,100萬美元，用於建立以色列首個生物晶片實驗室。該實驗室由以色列航空航太工業公司和貝克馬斯科技公司合作建立，旨在推動生物技術發展，並鞏固以色列在全球市場的地位。這項由該機構資助2056萬美元的計劃，凸顯了生物晶片作為科學和醫學進步關鍵要素的日益受到認可。政府在發展生物晶片基礎設施所做的努力，在市場成長中發揮至關重要的作用，加速了技術進步，並促進了生物晶片在全球各行業的應用。

生物晶片市場成長要素：

人口老化的進程

隨著全球預期壽命的延長，對能夠滿足老年人獨特需求的醫療保健解決方案的需求日益成長。這種人口結構的變化帶來了新的挑戰，尤其是在疾病的識別、追蹤和管理方面。世界衛生組織（WHO）預測，到2030年，全球六分之一的人口將超過60歲；到2050年，全球60歲以上人口預計將達到21億人。這些人口結構的變化推動了對高效診斷工具的需求，這些工具能夠及早識別和追蹤老年人常見的疾病，例如癌症、心血管疾病和糖尿病。生物晶片因其快速且準確的檢測結果而備受青睞，正成為滿足這些需求的理想解決方案，從而推動了醫療產業生物晶片市場的成長。

技術進步與創新

隨著先進高效生物晶片的不斷發展，其功能顯著提升，處理能力、通量和生物標記檢測精度均顯著提高。微陣列技術、小型化和感測器整合技術的進步，使得生物晶片能夠更快、更可靠地進行複雜分析。這些創新正在拓展生物晶片的應用範圍，尤其是在診斷、個人化醫療和藥物研發等領域，這些領域對準確性和速度要求極高。此外，人工智慧和機器學習技術與生物晶片技術的融合正在革新數據分析方式，從而提高預測精度並最佳化臨床決策。這些技術的融合增強了生物晶片的整體效能，並加速了其在醫療和研究領域的應用。隨著人們對更精準的診斷和治療方法的需求日益成長，能夠為各種醫療和研究用途提供尖端解決方案的生物晶片的需求也在加速成長。

擴大醫療保健服務範圍

人們對改善醫療服務可近性的日益關注是推動市場成長的關鍵因素。隨著醫療體系的不斷發展，對經濟高效的診斷工具的需求也日益成長。生物晶片提供了一種有效的解決方案，特別適用於實驗室設施有限的偏遠地區和醫療服務不足的地區。生物晶片體積小、易於使用且能快速提供結果，使其成為即時檢測的理想選擇。例如，西奈山醫療中心於2025年開設了新的海利亞東部門診部，將其基層醫療服務擴展到南佛羅裡達州醫療服務不足的地區。此次擴張符合該中心改善醫療服務可近性和公平性的使命。生物晶片的應用為這些努力提供了支持，因為它能夠實現快速且方便的診斷。隨著醫療基礎設施投資的增加，生物晶片正日益融入全球的醫療體系。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球生物晶片市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品類型分類

  • DNA晶片
  • 蛋白質晶片
  • Lab-On-a-Chip
  • 酵素晶片

第7章 市場區隔：依製造技術分類

  • 微陣列
  • 微流體

第8章 市場區隔：分析方法

  • 電泳
  • 發光的
  • 質譜分析
  • 電訊號
  • 磁性

第9章 市場區隔：依應用領域分類

  • 分子分析
    • 雜合反應
    • 蛋白質
    • 免疫學
    • 生物分子
    • 生物標記
    • 其他
  • 診斷
    • 基因診斷
    • 腫瘤學
    • 發炎
    • 其他
  • 非生物用途

第10章 市場區隔：依最終用戶分類

  • 製藥和生物技術公司
  • 醫院和診斷中心
  • 學術研究機構
  • 其他

第11章 市場區隔：按地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 俄羅斯
    • 義大利
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 其他
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他

第12章 SWOT 分析

第13章：價值鏈分析

第14章：波特五力分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Agilent Technologies, Inc.
    • bioMerieux SA
    • Bio-RAD Laboratories, Inc.
    • CapitalBio Corporation
    • Dynamic Biosensors GmbH
    • EMD Millipore Corporation
    • Fluidigm Corporation
    • Illumina, Inc.
    • Perkinelmer, Inc.
    • Thermo Fisher Scientific, Inc.
Product Code: SR112026A2741

The global biochips market size reached USD 25.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 77.6 Billion by 2034, exhibiting a growth rate (CAGR) of 12.88% during 2026-2034. North America dominates the market because of its robust healthcare system, considerable investments in research operations, and sophisticated medical technologies. The market is experiencing steady growth driven by innovations in next-generation sequencing and lab-on-a-chip technologies to enhance biochip capabilities, substantial funding from governments and private sectors for genetic and molecular research, and the increasing demand for personalized medicine.

As personalized medicine becomes more prevalent, biochips are essential in customizing treatments based on the genetic profile of an individual. These chips assist in identifying genetic mutations, early disease detection, and predicting drug responses, thereby catalyzing the demand for biochips in healthcare and pharmaceutical sectors. In addition, biochips are increasingly being utilized in point-of-care (POC) diagnostics, where immediate results are crucial for decision-making. Their ability to deliver quick, accurate results at the patient's location, whether at a clinic, in the field, or at home, is revolutionizing healthcare delivery. Apart from this, advancements in genomics, proteomics, and molecular biology are making biochips vital instruments for the analysis of biological samples. This enables quicker, more accurate research and diagnostics, rendering them essential in laboratories, hospitals, and clinical environments.

Biochips Market Trends:

Rising Demand for Personalized Medicine

Healthcare providers are progressively embracing a more personalized strategy to treatment, concentrating on the distinct genetic composition and biomarker characteristics of every patient. Biochips are ideal for performing the essential genetic evaluations needed to establish individualized treatment strategies. Their capacity to quickly identify particular genetic mutations, variations, and gene expressions allows healthcare providers to customize treatments for the best patient results. With the rise of precision medicine, there is an increase in the need for biochips capable of conducting comprehensive, high-throughput screening and diagnostic evaluations. These sophisticated biochips can manage intricate biological information and support more precise therapies, allowing doctors to offer improved care for their patients. As a result, biochips are becoming essential instruments in the continuous progress of personalized medicine.

Advancements in 3D Printing and Microfluidic Biochips

Progress in 3D printing and microfluidic biochips is considerably supporting the expansion of the biochips market. The capability to accurately replicate human organ functions is transforming research in life sciences and pharmaceutical testing. In May 2024, Boston Micro Fabrication (BMF) established BMF Biotechnology Inc., a division dedicated to 3D-printed organ-on-a-chip BioChips. These microfluidic systems provided improved biological precision over conventional models, facilitating quicker and more accurate research results. This advancement enhanced drug testing, cosmetic safety, and treatment forecasting by delivering more accurate simulations of human organs. Such innovations are expanding the limits of biological research and opening up new possibilities for biochip uses, especially in personalized medicine and drug development. The ongoing advancement of 3D-printed biochips improves their effectiveness, increasing the need for innovative biochip technologies in multiple research and healthcare fields.

Government Support and Investments in Biotechnology

Support from the government and targeted investments in biotechnology are crucial factors propelling the growth of the biochips market. Through the funding of pioneering projects, governments are facilitating the advancement of cutting-edge biochip technologies applicable to multiple fields, such as healthcare, research, and high-tech sectors. A notable instance of this is the US$31 million funding by the Israel Innovation Authority in 2024 to establish the nation's inaugural biochip lab. Created in partnership with Israel Aerospace Industries and Beckermus Technologies, this laboratory aimed to promote biotechnology and strengthen Israel's position in the global market. With US$20.56 million in funding provided by the Authority, this initiative underscored the growing acknowledgment of biochips as essential elements for advancements in science and medicine. Government initiatives aimed at developing biochip infrastructure play a crucial role in market growth, enhancing technological advancements and easing the integration of biochips in industries worldwide.

Biochips Market Growth Drivers:

Growing Geriatric Population

With the global rise in life expectancy, there is a higher need for healthcare solutions that can meet the unique requirements of an older demographic. This demographic shift presents novel challenges, particularly in disease identification, tracking, and management. The World Health Organization (WHO) states that by 2030, one in six individuals globally will be 60 years or older, and by 2050, the worldwide population of people aged 60 and over is anticipated to increase to 2.1 billion. This changing demographic is catalyzing the demand for efficient diagnostic tools capable of identifying illnesses at early stages and tracking chronic conditions, like cancer, cardiovascular diseases, and diabetes, which are more common among older individuals. Biochips, recognized for their swift and precise outcomes, are becoming an optimal answer to satisfy these needs, fueling the growth of the biochips market within healthcare industries.

Technological Advancements and Innovation

The ongoing advancement of advanced and efficient biochips is greatly improving the functionalities of biochips, allowing for better processing power, enhanced throughput, and higher accuracy in detecting biological markers. Advancements in microarray technology, miniaturization, and sensor integration enable biochips to conduct intricate analyses more quickly and reliably. These innovations are broadening the uses of biochips, particularly in diagnostics, personalized medicine, and drug discovery, where accuracy and speed are essential. Moreover, the incorporation of AI and ML with biochip technology is transforming data analysis, allowing for enhanced predictions and better clinical decision-making. This combination of technologies improves the overall efficacy of biochips and encourages their use in healthcare and research domains. The growing need for improved diagnostics and precise therapies is catalyzing the demand for biochips fot providing cutting-edge options for various medical and research purposes.

Expansion of Healthcare Access

The increasing emphasis on enhancing healthcare access is a crucial factor contributing to the market growth. As healthcare systems develop, the demand for affordable and efficient diagnostic tools grows. Biochips provide an effective answer, particularly in distant or underserved regions where sophisticated lab facilities might be limited. Their small dimensions, simplicity of operation, and capability to deliver quick outcomes render biochips perfect for point-of-care environments. For example, in 2025, Mount Sinai Medical Center expanded primary care services to underserved communities in South Florida with the opening of its new Hialeah East outpatient facility. This expansion supports their mission to improve healthcare access and equity. Such efforts benefits from the deployment of biochips for quick, accessible diagnostics. As investments in healthcare infrastructure grow, biochips are increasingly being integrated into global healthcare systems.

Biochips Market Segmentation:

The publisher provides an analysis of the key trends in each segment of the global biochips market report, along with forecasts at the global, regional, and country levels for 2026-2034. Our report has categorized the market based on product type, fabrication technique, analysis method, application, and end user.

Breakup by Product Type:

  • DNA Chip
  • Protein Chip
  • Lab-On-a-Chip
  • Enzyme Chip

DNA Chip represents the largest market segment

DNA chips, otherwise called DNA microarrays, are currently the largest product type in the market. This can be supported by the wide application spectrum and technological advances. These chips facilitate large-scale analyses of genetic information; such chips become core tools in genomics, diagnostics, and personalized medicine. Thousands of genes can be analyzed simultaneously, hence making landmark changes in research related to cancer genomics, genetic disorder screening, and pharmacogenomics. It is resulting in more sensitive, specific, and efficient DNA chips with upgraded technologies, thereby increasing adoption. According to the biochips market report, the growing interest in precision medicine and health treatments by individual genomics also accelerates the demand for DNA chips. Key players in the marketplace are engaged in extensive research and development to come up with new products in DNA chips, thereby helping the changing requirements of healthcare and biotech companies. Apart from this, increasing incidences of genetic disorders and chronic diseases require detailed genetic profiling, and thus, DNA chips assume a significant role in contemporary diagnostics and therapy. DNA chips, therefore, hold a greater share in the biochips market since they represent a vital constituent in promoting molecular biology and individualistic healthcare solutions.

Breakup by Fabrication Technique:

  • Microarray
  • Microfluidic

Microarray represents the largest market segment

Microarray technology is the most widely used fabrication technique in this market due to its versatility and efficiency for different applications. This method permits large amounts of biological data to be analyzed at the same time and is used in genomics, transcriptomics, and proteomic studies. The biochips market forecast suggests that quantification of gene or protein expression across the spectrum in a single experiment is game-changing for drug discovery, disease diagnosis, and personalized medicine. New microarray technologies support more accurate, faster, and scaled-up biochip fabrication to enable reliable detection over large fractions of the corresponding user population. Microarray technology is widely used in the healthcare and bioinformatics sectors to improve research activities, as well as help introduce new targeted therapies. Additionally, their integration with modern data analysis techniques and bioinformatics platforms is further expanding the use of microarrays for understanding complex biological processes. With the growth of personalized medicine, the coming years will see a great increase in demand for accurate and high-throughput analytical platforms such as microarrays. Hence, microarray technology continues to be the leading method of manufacturing in the marketplace and plays a foundational role in propelling biomedical research forward as well as improving clinical diagnostics.

Breakup by Analysis Method:

  • Electrophoresis
  • Luminescence
  • Mass Spectrometry
  • Electrical Signals
  • Magnetism

Electrophoresis represents the largest market segment

Electrophoresis is the most dominant method of analysis in biochips due to its wide applicability, strength, and precision in separation techniques, and the analysis of biological molecules. This also represents a vital technique in functional genomics, proteomics, and molecular biology through the effective separation of DNA, RNA, and proteins, based on size and charge, offering a view into their structure and function. According to the biochips market overview, electrophoresis is being utilized in several research and routine laboratories, especially in tasks related to genetic mapping, disease diagnosis, and forensic analysis. This, in addition to being a robust and accurate system, permitted working in unison with advanced biochip technologies to ensure better resolution and higher throughput of molecular analyses. Electrophoresis techniques, including capillary and microfluidic electrophoresis, have recently been innovated to further enhance its operations, moving faster and offering more detailed examinations. Evident through the increasing need for high-precision analytical tools within the fields of personalized medicine and biotechnology, electrophoresis is set to remain prominent. Moreover, it consolidates a central position as the leading analysis method in the market with the escalating complex biological systems and disease mechanisms.

Breakup by Application:

  • Molecular Analysis
  • Hybridization
  • Protein
  • Immunological
  • Biomolecules
  • Biomarker
  • Others
  • Diagnosis
  • Gene Diagnosis
  • Oncology
  • Inflammatory
  • Others
  • Non-Biological Usage

Diagnosis represents the largest market segment

Diagnosis is the largest application in the market as an accurate, fast, and comprehensive diagnostic tool is necessary in healthcare. Biochips are revolutionizing the concept of diagnosis in that they can analyze multiple biomarkers in a single chip, helping in the early and accurate detection of diseases. Therefore, this is escalating the biochips demand. This is important in managing chronic and infectious diseases, such as cancer, cardiovascular disorders, and emerging viral infections. These factors are leading to the integration of biochips in diagnostic platforms, which further resulted in enhanced specificity and sensitivity of tests, thereby leading toward better patient outcomes, based on test results, through timely and targeted interventions. Apart from this, progress in biochip technology in the form of microarrays and lab-on-a-chip systems has made things easier, cost-effective, and more accessible at the diagnostic level. The stakes for diagnostics based on biochips are further raised by the rise of personalized medicine, as these will be able to render analyses of genetic profiles to administer treatments on an individual basis. With the changing landscape of healthcare across the globe toward precision and preventive medicine, the adoption of biochips for diagnostic purposes is gaining considerable ground, which essentially sets this as a cornerstone in modern medical diagnostics and fuels the biochips market growth.

Breakup by End User:

  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Diagnostics Centers
  • Academic and Research Institutes
  • Others

Pharmaceutical and biotechnology companies represent the largest market segment

The largest end users in the biochips industry are pharmaceuticals and biotechnology firms. This can be attributed to their extensive research and development activities and increased demand for new and fresh solutions in drug discovery and development processes. Biochips help these sectors immensely in areas such as high-throughput screening, gene analysis, and biomarker identification for the comprehension of the mechanisms of diseases and the subsequent development of targeted therapies. Additionally, biochip technology makes possible new technologically precise, faster, and less expensive methods that hasten drug development and inform and facilitate the planning of clinical trials, hence putting personalized medicine into action with detailed molecular insight. In regard to this, the heavy investments in biochip technology by the studied firms is to improve efficiency and lower development costs. Moreover, close collaboration between the manufacturers of biochips and pharmaceutical and biotech companies fosters further improved forms of biochips tailored to special research needs. With continued pressure from the rising need for new therapeutics and personalized treatment options, there is a growing reliance on biochips within these industries, and it can create a critical difference in innovating and building a competitive edge to deal with the transforming environment of healthcare.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Russia
  • Italy
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Others
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Others
  • Middle East and Africa
  • Turkey
  • Saudi Arabia
  • United Arab Emirates
  • Others

North America leads the market, accounting for the largest biochips market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Spain, Russia, Italy, and others); Asia Pacific (China, India, Japan, South Korea, Australia, and others); Latin America (Mexico, Brazil, Argentina, and others); and the Middle East and Africa (Turkey, Saudi Arabia, United Arab Emirates, and others). According to the report, North America represents the largest regional market for biochips.

The North America region is the largest contributor to the biochips market due to high-quality healthcare infrastructure and substantial investments in biotechnology research, followed by Asia-Pacific being robustly driven by technological innovation. Besides, the sovereignty of this region is also driven by some major market players in biotech, such as Samsung Biologics and Celltrion, along with comprehensive government support for R&D activities. Along with this, rising chronic diseases and personalized medicine requirements are further fueling a rise in the usage of biochip technologies. Prospective growth opportunities for this market in major countries such as the U.S. and Canada are propelling regional expansion due to genomics and proteomics research grants which are augmenting the biochips market revenue. In addition, the presence of mature pharmaceutical and biotechnology industries in North America allows expeditious commercialization and adoption of biochip applications across diverse healthcare settings.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the biochips industry include:

  • Agilent Technologies, Inc.
  • bioMerieux SA
  • Bio-RAD Laboratories, Inc.
  • CapitalBio Corporation
  • Dynamic Biosensors GmbH
  • EMD Millipore Corporation
  • Fluidigm Corporation
  • Illumina, Inc.
  • Perkinelmer, Inc.
  • Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

The leading biochips companies are engaged in research and development with respect to new products and technological innovations to enhance the existing technology. Major companies such as Illumina, Thermo Fisher Scientific, and Agilent Technologies execute next-generation sequencing and lab-on-chip systems. This develops sensitivity, accuracy, and throughput, hence meeting demand for precise diagnostic and research tools. Such strategic collaborations, mergers, and acquisitions often allow these firms to develop their product line and increase their geographical presence. They are also integrating the biochip technology with artificial intelligence and machine learning, which enhances the data analysis capability. These major players, therefore, meet changing requirements in personalized medicine, diagnostics, and drug discovery, hence maintaining a competitive edge and accelerating the market growth.

Key Questions Answered in This Report:

  • How has the global biochips market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global biochips market?
  • What is the impact of each driver, restraint, and opportunity on the global biochips market?
  • What are the key regional markets?
  • Which countries represent the most attractive biochips market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the biochips market?
  • What is the breakup of the market based on the fabrication technique?
  • Which is the most attractive fabrication technique in the biochips market?
  • What is the breakup of the market based on the analysis method?
  • Which is the most attractive analysis method in the biochips market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the biochips market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the biochips market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global biochips market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biochips Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 DNA Chip
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Protein Chip
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Lab-On-a-Chip
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Enzyme Chip
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Fabrication Technique

  • 7.1 Microarray
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Microfluidic
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Analysis Method

  • 8.1 Electrophoresis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Luminescence
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Mass Spectrometry
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Electrical Signals
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Magnetism
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Molecular Analysis
    • 9.1.1 Hybridization
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Protein
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
    • 9.1.3 Immunological
      • 9.1.3.1 Market Trends
      • 9.1.3.2 Market Forecast
    • 9.1.4 Biomolecules
      • 9.1.4.1 Market Trends
      • 9.1.4.2 Market Forecast
    • 9.1.5 Biomarker
      • 9.1.5.1 Market Trends
      • 9.1.5.2 Market Forecast
    • 9.1.6 Others
      • 9.1.6.1 Market Trends
      • 9.1.6.2 Market Forecast
  • 9.2 Diagnosis
    • 9.2.1 Gene Diagnosis
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Oncology
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 Inflammatory
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 Others
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
  • 9.3 Non-Biological Usage
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Pharmaceutical and Biotechnology Companies
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals and Diagnostics Centers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Academic & Research Institutes
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Europe
    • 11.2.1 Germany
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 France
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 United Kingdom
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 Spain
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Russia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Italy
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Asia Pacific
    • 11.3.1 China
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 India
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 Japan
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 South Korea
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Australia
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Others
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Mexico
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Brazil
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Argentina
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
    • 11.4.4 Others
      • 11.4.4.1 Market Trends
      • 11.4.4.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Turkey
      • 11.5.1.1 Market Trends
      • 11.5.1.2 Market Forecast
    • 11.5.2 Saudi Arabia
      • 11.5.2.1 Market Trends
      • 11.5.2.2 Market Forecast
    • 11.5.3 United Arab Emirates
      • 11.5.3.1 Market Trends
      • 11.5.3.2 Market Forecast
    • 11.5.4 Others
      • 11.5.4.1 Market Trends
      • 11.5.4.2 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 bioMerieux SA
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bio-RAD Laboratories, Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 CapitalBio Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Dynamic Biosensors GmbH
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 EMD Millipore Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Fluidigm Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Illumina, Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Perkinelmer, Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Thermo Fisher Scientific, Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Biochips Market: Major Drivers and Challenges
  • Figure 2: Global: Biochips Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Biochips Market: Breakup by Product Type (in %), 2025
  • Figure 4: Global: Biochips Market: Breakup by Fabrication Technique (in %), 2025
  • Figure 5: Global: Biochips Market: Breakup by Analysis Method (in %), 2025
  • Figure 6: Global: Biochips Market: Breakup by Application (in %), 2025
  • Figure 7: Global: Biochips Market: Breakup by End User (in %), 2025
  • Figure 8: Global: Biochips Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Biochips Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 10: Global: Biochips (DNA Chip) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Biochips (DNA Chip) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Biochips (Protein Chip) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Biochips (Protein Chip) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Biochips (Lab-On-a-Chip) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Biochips (Lab-On-a-Chip) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Biochips (Enzyme Chip) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Biochips (Enzyme Chip) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Biochips (Microarray) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Biochips (Microarray) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Biochips (Microfluidic) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Biochips (Microfluidic) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Biochips (Electrophoresis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Biochips (Electrophoresis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Biochips (Luminescence) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Biochips (Luminescence) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Biochips (Mass Spectrometry) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Biochips (Mass Spectrometry) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Biochips (Electrical Signals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Biochips (Electrical Signals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Biochips (Magnetism) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Biochips (Magnetism) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Biochips (Molecular Analysis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Biochips (Molecular Analysis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Biochips (Hybridization) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Biochips (Hybridization) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Biochips (Protein) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Biochips (Protein) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Biochips (Immunological) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Biochips (Immunological) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Global: Biochips (Biomolecules) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Global: Biochips (Biomolecules) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Global: Biochips (Biomarker) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Global: Biochips (Biomarker) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Global: Biochips (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Global: Biochips (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Global: Biochips (Diagnosis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Global: Biochips (Diagnosis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Global: Biochips (Gene Diagnosis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Global: Biochips (Gene Diagnosis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Global: Biochips (Oncology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Global: Biochips (Oncology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Global: Biochips (Inflammatory) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Global: Biochips (Inflammatory) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Global: Biochips (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Global: Biochips (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Global: Biochips (Non-Biological Usage) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Global: Biochips (Non-Biological Usage) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Global: Biochips (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Global: Biochips (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Global: Biochips (Hospitals and Diagnostics Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Global: Biochips (Hospitals and Diagnostics Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Global: Biochips (Academic & Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Global: Biochips (Academic & Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Global: Biochips (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Global: Biochips (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: North America: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: North America: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: United States: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: United States: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Canada: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Canada: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Europe: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Europe: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Germany: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Germany: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: France: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: France: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: United Kingdom: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: United Kingdom: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Spain: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Spain: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Russia: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Russia: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Italy: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Italy: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Others: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Others: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Asia Pacific: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 89: Asia Pacific: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 90: China: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 91: China: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 92: India: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 93: India: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 94: Japan: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 95: Japan: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 96: South Korea: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 97: South Korea: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 98: Australia: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 99: Australia: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 100: Others: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 101: Others: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 102: Latin America: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 103: Latin America: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 104: Mexico: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 105: Mexico: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 106: Brazil: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 107: Brazil: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 108: Argentina: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 109: Argentina: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 110: Others: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 111: Others: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 112: Middle East and Africa: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 113: Middle East and Africa: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 114: Turkey: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 115: Turkey: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 116: Saudi Arabia: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 117: Saudi Arabia: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 118: United Arab Emirates: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 119: United Arab Emirates: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 120: Others: Biochips Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 121: Others: Biochips Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 122: Global: Biochips Industry: SWOT Analysis
  • Figure 123: Global: Biochips Industry: Value Chain Analysis
  • Figure 124: Global: Biochips Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biochips Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Biochips Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Biochips Market Forecast: Breakup by Fabrication Technique (in Million USD), 2026-2034
  • Table 4: Global: Biochips Market Forecast: Breakup by Analysis Method (in Million USD), 2026-2034
  • Table 5: Global: Biochips Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 6: Global: Biochips Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 7: Global: Biochips Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 8: Global: Biochips Market: Competitive Structure
  • Table 9: Global: Biochips Market: Key Players